These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24014597)

  • 1. TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase.
    Wang X; Saso H; Iwamoto T; Xia W; Gong Y; Pusztai L; Woodward WA; Reuben JM; Warner SL; Bearss DJ; Hortobagyi GN; Hung MC; Ueno NT
    Cancer Res; 2013 Nov; 73(21):6516-25. PubMed ID: 24014597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibition of Axl receptor tyrosine kinase potently suppresses multiple malignant properties of glioma cells.
    Vouri M; An Q; Birt M; Pilkington GJ; Hafizi S
    Oncotarget; 2015 Jun; 6(18):16183-97. PubMed ID: 25980499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion.
    Li W; Xiong X; Abdalla A; Alejo S; Zhu L; Lu F; Sun H
    J Biol Chem; 2018 Oct; 293(40):15397-15418. PubMed ID: 30108175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma.
    Liu R; Gong M; Li X; Zhou Y; Gao W; Tulpule A; Chaudhary PM; Jung J; Gill PS
    Blood; 2010 Jul; 116(2):297-305. PubMed ID: 20442363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.
    Linger RM; Cohen RA; Cummings CT; Sather S; Migdall-Wilson J; Middleton DH; Lu X; Barón AE; Franklin WA; Merrick DT; Jedlicka P; DeRyckere D; Heasley LE; Graham DK
    Oncogene; 2013 Jul; 32(29):3420-31. PubMed ID: 22890323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axl Is a Potential Cancer Prognostic Marker for the Migration and Invasion of Nasopharyngeal Carcinoma.
    Jiang C; Zhou L; Wang H; Zhang Q; Xu Y
    Adv Clin Exp Med; 2016; 25(3):531-7. PubMed ID: 27629742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma.
    Xu MZ; Chan SW; Liu AM; Wong KF; Fan ST; Chen J; Poon RT; Zender L; Lowe SW; Hong W; Luk JM
    Oncogene; 2011 Mar; 30(10):1229-40. PubMed ID: 21076472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting receptor tyrosine kinase AXL with small molecule inhibitor BMS-777607 reduces glioblastoma growth, migration, and invasion in vitro and in vivo.
    Onken J; Torka R; Korsing S; Radke J; Krementeskaia I; Nieminen M; Bai X; Ullrich A; Heppner F; Vajkoczy P
    Oncotarget; 2016 Mar; 7(9):9876-89. PubMed ID: 26848524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival.
    Ammoun S; Provenzano L; Zhou L; Barczyk M; Evans K; Hilton DA; Hafizi S; Hanemann CO
    Oncogene; 2014 Jan; 33(3):336-46. PubMed ID: 23318455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma.
    Paccez JD; Duncan K; Vava A; Correa RG; Libermann TA; Parker MI; Zerbini LF
    Mol Biol Cell; 2015 Mar; 26(5):821-31. PubMed ID: 25568334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer.
    Avilla E; Guarino V; Visciano C; Liotti F; Svelto M; Krishnamoorthy G; Franco R; Melillo RM
    Cancer Res; 2011 Mar; 71(5):1792-804. PubMed ID: 21343401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of AXL in invasion and drug resistance of colon and breast cancer cells and its association with p53 alterations.
    Abdel-Rahman WM; Al-Khayyal NA; Nair VA; Aravind SR; Saber-Ayad M
    World J Gastroenterol; 2017 May; 23(19):3440-3448. PubMed ID: 28596680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skipping of exon 10 in
    Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
    Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer.
    Divine LM; Nguyen MR; Meller E; Desai RA; Arif B; Rankin EB; Bligard KH; Meyerson C; Hagemann IS; Massad M; Thaker PH; Hagemann AR; McCourt CK; Powell MA; Mutch DG; Fuh KC
    Oncotarget; 2016 Nov; 7(47):77291-77305. PubMed ID: 27764792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA LINC00526 represses glioma progression via forming a double negative feedback loop with AXL.
    Yan J; Xu C; Li Y; Tang B; Xie S; Hong T; Zeng E
    J Cell Mol Med; 2019 Aug; 23(8):5518-5531. PubMed ID: 31240814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA.
    Mackiewicz M; Huppi K; Pitt JJ; Dorsey TH; Ambs S; Caplen NJ
    Breast Cancer Res Treat; 2011 Nov; 130(2):663-79. PubMed ID: 21814748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma.
    Hector A; Montgomery EA; Karikari C; Canto M; Dunbar KB; Wang JS; Feldmann G; Hong SM; Haffner MC; Meeker AK; Holland SJ; Yu J; Heckrodt TJ; Zhang J; Ding P; Goff D; Singh R; Roa JC; Marimuthu A; Riggins GJ; Eshleman JR; Nelkin BD; Pandey A; Maitra A
    Cancer Biol Ther; 2010 Nov; 10(10):1009-18. PubMed ID: 20818175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target.
    Koorstra JB; Karikari CA; Feldmann G; Bisht S; Rojas PL; Offerhaus GJ; Alvarez H; Maitra A
    Cancer Biol Ther; 2009 Apr; 8(7):618-26. PubMed ID: 19252414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappaB and Brg-1.
    Tai KY; Shieh YS; Lee CS; Shiah SG; Wu CW
    Oncogene; 2008 Jul; 27(29):4044-55. PubMed ID: 18345028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell softening in malignant progression of human lung cancer cells by activation of receptor tyrosine kinase AXL.
    Iida K; Sakai R; Yokoyama S; Kobayashi N; Togo S; Yoshikawa HY; Rawangkan A; Namiki K; Suganuma M
    Sci Rep; 2017 Dec; 7(1):17770. PubMed ID: 29259259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.